Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. Clinical relevance of CD44 cell-surface expression and N-myc gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results